Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy.
Whiteside
T L
TL
Pittsburgh Cancer Institute, PA 15213.
Jost
L M
LM
Herberman
R B
RB
D006801:Humans; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000627:therapeutic use; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*
D007376:Interleukin-2